Standard BioTools Inc. Share Price & Technical Analysis
LAB · $1.03 (-0.96%)
Healthcare / Medical Devices
$1.03
-0.96%
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consuma…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
11% return in May, 9% avg return in past 3 year May month.
-21% return in 2026, 46% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 8% | -21% | -18% | 0% | 11% | – | – | – | – | – | – | – | -21% |
| 25 | -17% | -27% | 10% | 0% | -9% | 20% | 8% | 0% | 8% | -8% | 25% | -13% | -2% |
| 24 | 5% | -4% | 23% | -7% | 0% | -28% | 22% | 31% | -10% | 5% | -10% | 0% | 27% |
| 23 | 67% | -10% | 11% | -11% | 35% | -17% | 32% | 25% | -3% | -31% | 30% | -15% | 112% |
| 22 | -15% | 12% | -3% | -25% | -32% | -16% | -6% | 0% | -21% | 9% | 27% | -14% | -84% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$386.66M
P/E ratio
—
52W high
$1.72
52W low
$0.87
Volume
11,49,840
Beta
1.31
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Standard BioTools Inc. share price today?
- Standard BioTools Inc. (LAB) last traded around $1.03 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LAB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LAB. Download the app for real-time alerts.
- How can I analyze Standard BioTools Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.